As Enhertu’s reach continues to spread into additional forms of breast cancer, Daiichi Sankyo and AstraZeneca are ramping up ...

AstraZeneca (AZN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Eric Le ...

Shares of AstraZeneca (LON:AZN) dropped on Thursday following the presentation of disappointing final overall survival data ...

When AstraZeneca’s Alexion picked up rare disease specialist Syntimmune in 2018 for $ | A Delaware judge agreed that ...

The partners’ ADC didn’t significantly extend survival in lung cancer patients who were expected to benefit the most from ...

On Friday, the US Food and Drug Administration approved UK pharma major AstraZeneca’s (LSE: AZN) FluMist for self- or ...

Welcome, ladies and gentlemen, to AstraZeneca's Investor Conference ... but I think we have the commercial execution in place to be able to bring along this change as well. So, as Professor ...

Global biopharmaceutical company, AstraZeneca is set to investigate the effectiveness of using artificial intelligence for heart screening.

Among the first presentations at the European Society for Medical Oncology (ESMO) meeting that kicked off today, were results ...

HALIX B.V., a leading contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of ...